Penumbra Stock Today
| PEN Stock | USD 296.00 4.18 1.43% |
PerformanceModest
| Odds Of DistressLow
|
Penumbra is selling at 296.00 as of the 4th of May 2025; that is 1.43 percent increase since the beginning of the trading day. The stock's open price was 291.82. Penumbra has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 3rd of February 2025 and ending today, the 4th of May 2025. Click here to learn more.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 38.73 M outstanding shares of which 1.57 M shares are at this time shorted by investors with about 3.52 days to cover. More on Penumbra
Moving against Penumbra Stock
| 0.39 | VTAK | Catheter Precision Earnings Call Tomorrow | PairCorr |
Penumbra Stock Highlights
| Chairman | Adam Elsesser |
| Old Names | [Pennant Energy Inc., Petrolimex Installation No III JSC] |
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, PX Prague Stock, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Penumbra (PEN) is traded on New York Stock Exchange in USA. It is located in One Penumbra Place, Alameda, CA, United States, 94502 and employs 4,500 people. Penumbra is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 11.3 B. Penumbra runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 38.73 M outstanding shares of which 1.57 M shares are at this time shorted by investors with about 3.52 days to cover.
Penumbra has about 69.86 M in cash with 168.48 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.39.
Check Penumbra Probability Of Bankruptcy
Ownership AllocationPenumbra owns a total of 38.73 Million outstanding shares. The majority of Penumbra outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Penumbra to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Penumbra. Please pay attention to any change in the institutional holdings of Penumbra as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Penumbra Ownership Details
Penumbra Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Penumbra market risk premium is the additional return an investor will receive from holding Penumbra long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.1283 | |||
| Jensen Alpha | 0.1901 | |||
| Total Risk Alpha | 0.398 | |||
| Sortino Ratio | 0.1445 |
Penumbra Stock Against Markets
Penumbra Corporate Directors
| Surbhi Sarna | Independent Director | Profile | |
| Bridget ORourke | Independent Director | Profile | |
| Holly Sit | Director Development | Profile | |
| Harpreet Grewal | Independent Director | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.